featured
Risk of Cutaneous Squamous Cell Carcinoma After Treatment of Basal Cell Carcinoma With Vismodegib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Cutaneous Squamous Cell Carcinoma After Treatment of Basal Cell Carcinoma With Vismodegib
J Am Acad Dermatol 2017 Aug 02;[EPub Ahead of Print], T Bhutani, M Abrouk, CS Sima, N Sadetsky, J Hou, I Caro, MM Chren, ST ArronFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.